Apixaban Dosing to Optimize Protection From Thrombosis - ADOPT

Description:

It is unclear if extended venous thromboembolism (VTE) prophylaxis is beneficial in acutely ill patients. The current trial sought to study the safety and efficacy of extended use of apixaban as compared with short-term use of enoxaparin in these patients.